Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label, Randomized, Multi-Center Study for Safety and Efficacy Evaluation of Inhaled Nitric Oxide (NO) Given Intermittently to Adults With Viral Pneumonia

NCT04606407 is registered in ClinicalTrials.gov with Beyond Air Inc. as lead sponsor.

NCT NCT04606407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04606407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label, Randomized, Multi-Center Study for Safety and Efficacy Evaluation of Inhaled Nitric Oxide (NO) Given Intermittently to Adults With Viral Pneumonia
Lead sponsor
Beyond Air Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 25, 2020
Completion date
August 7, 2022
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, inhaled nitric oxide, nitric oxide, pneumonia, viral, respiratory disease, sars-cov infection, viral pneumonia